- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07643857
Circular Staplers and Anastomotic Leak After Colorectal Surgery (PROTECT)
Prospective Evaluation of the Impact of New Circular Stapler Technology in Colorectal Anastomosis: the PROTECT Study
The goal of this observational study is to evaluate whether different circular stapling devices influence the success of the surgical connection between the bowel ends after colorectal cancer surgery in patients undergoing colorectal resection using different stapling devices.
The main question this study aims to answer is whether different circular stapling devices affect the risk of a leak developing at the site where the bowel is reconnected after colorectal cancer surgery.
Researchers will compare three types of circular stapling devices commonly used in clinical practice (two-row, three-row, and powered circular staplers) to determine whether they are associated with different risks of leakage at the site where the bowel is reconnected after colorectal cancer surgery.
Participants will receive standard medical care. Taking part in this study will not affect their treatment, and no additional procedures, tests, or visits are required as part of the study.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Stefano Agnesi, MD
- Numéro de téléphone: +390353063612
- E-mail: stefano.agnesi@asst-bergamoest.it
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Adult patients (18 years or older)
- Patients undergoing elective surgery, either open or minimally invasive (laparoscopic or robotic), for anterior rectal resection, sigmoid resection, or left hemicolectomy for colorectal cancer with concomitant colorectal anastomosis (Knight-Griffen technique) using one of the circular stapler types under investigation (two-row CS, three-row CS, PCS).
Exclusion Criteria:
- Patients undergoing emergency surgery
- Patients undergoing additional surgical procedures during the same operation (e.g., cholecystectomy, liver resection, etc.)
- Patients with documented metastases at preoperative staging (cM+)
- Patients under 18 years of age
- Lack of informed consent
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Patients undergoing colorectal cancer surgery with primary anastomosis
Patients undergoing elective surgery for anterior rectal resection, sigmoid resection, or left hemicolectomy for colorectal cancer with concomitant colorectal anastomosis (Knight-Griffen technique) using one of the circular stapler types under investigation (two-row circular stapler, three-row circular stapler, powered circular stapler).
|
Two-row circular stapler: circular stapling device creating a colorectal anastomosis using two concentric rows of staples.
The device is used according to routine clinical practice during colorectal resection with primary anastomosis.
Three-row circular stapler: circular stapling device creating a colorectal anastomosis using three concentric rows of staples with graduated staple heights designed to optimize tissue compression and sealing.
The device is used according to routine clinical practice during colorectal resection with primary anastomosis.
Powered circular stapler: electrically powered circular stapling device used to create a colorectal anastomosis.
The powered mechanism is designed to standardize tissue compression and stapler firing while reducing operator-dependent variability.
The device is used according to routine clinical practice during colorectal resection with primary anastomosis.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
|---|---|
|
Anastomotic leakage
Délai: From the date of surgery until the first occurrence of anastomotic leakage, assessed up to 30 days after surgery
|
From the date of surgery until the first occurrence of anastomotic leakage, assessed up to 30 days after surgery
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
|---|---|
|
Postoperative complications
Délai: From the date of surgery until the first occurrence of any postoperative complications, assessed up to 30 days after surgery
|
From the date of surgery until the first occurrence of any postoperative complications, assessed up to 30 days after surgery
|
|
Reintervention rate
Délai: From the date of surgery until the first reintervention, assessed up to 30 days after index surgery
|
From the date of surgery until the first reintervention, assessed up to 30 days after index surgery
|
|
Postoperative length of stay
Délai: From date of surgery until the date of hospital discharge, average 1 week
|
From date of surgery until the date of hospital discharge, average 1 week
|
Collaborateurs et enquêteurs
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- PROTECT study
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .